3 European funding rounds and $175.8M disclosed. Swap leads the edition; explore the companies, investors and stage breakdown.
Its $100M round represents 57% of the $175.8M disclosed across this edition. Swap is an ecommerce solutions platform that provides agentic storefronts, cross-border shipping, returns management, and compliance tools for global brands.
Bactolife, FineHeart are among the companies in the most active sector by number of rounds in this edition.
Pre-seed, seed and Series A account for 0 of the 3 announcements. These rounds total $0 in disclosed funding.
3 rounds · $175.8M disclosed · $40.7M median
| Company | Amount | Stage / sector | Lead investor | Announced |
|---|---|---|---|---|
| FineHeart A clinical-stage medical technology company developing FlowMaker, an intracardiac pump for the treatment of advanced heart failure. | €35M | Series C+ Healthtech | — | |
| Bactolife Bactolife empowers worldwide health through a fortified gut microbiome. | €30M | Series B Healthtech | — | |
| Swap Swap is an ecommerce solutions platform that provides agentic storefronts, cross-border shipping, returns management, and compliance tools for global brands. | $100M | Series C+ E-commerce | — |
A clinical-stage medical technology company developing FlowMaker, an intracardiac pump for the treatment of advanced heart failure.
Bactolife empowers worldwide health through a fortified gut microbiome.
Swap is an ecommerce solutions platform that provides agentic storefronts, cross-border shipping, returns management, and compliance tools for global brands.
47 European funding rounds and $2.1B disclosed. Parloa leads the edition; explore the companies, investors and stage breakdown.
6 European funding rounds and $634.2M disclosed. Parloa leads the edition; explore the companies, investors and stage breakdown.
17 European funding rounds and $1B disclosed. Mews leads the edition; explore the companies, investors and stage breakdown.